Clinical trial Recruiting at 1 site Interventional Ages Any age to 7

Lowering lead dust in older homes with portable air filters

Official title: Reducing Lead Dust Exposure and Childhood Blood Lead Levels in Older Housing in Michigan

Run by Michigan State University · NCT07485608 · Data updated 2026-11-12

This project will test whether portable air filters in older homes can reduce lead dust and lower blood lead levels in young children with elevated readings.

Quick facts

Study typeInterventional
AgesAny age to 7 Years
SexAll
Enrollment40 (estimated)
SponsorMichigan State University
Academic / other
Locations1 site (East Lansing, Michigan)
StatusRecruiting
StartedDecember 1, 2022
Main results expectedJuly 3, 2026
Study endsNovember 30, 2026
Registry record updatedNovember 5, 2026
Trial IDNCT07485608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children under seven years old who live in homes built before 1978, have blood lead levels above 5 µg/dL, and sleep at home during the two-month intervention are ideal candidates.

Probably not a fit

Children living in newer housing, whose lead exposure comes mainly from non-indoor sources, or whose medical conditions affect lead metabolism may not see benefit from home air filtration alone.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In collaboration with local health departments, the team will enroll 40 households with children under seven who have blood lead levels above 5 µg/dL and live in homes built before 1978. Portable air filtration (PAF) units will be placed in participating homes for a two-month intervention. The study measures lead in suspended dust, floor dust, and children's blood before the intervention, at midpoint, and after two months to see if reductions in dust correspond to lower blood lead levels. Results will be used to develop evidence-based guidance for wider public use of PAF to reduce lead exposures.

Why it matters

Potential benefit: If successful, using portable air filters could lower indoor lead dust and help reduce children's blood lead levels, decreasing risks of lead-related health problems.

How similar studies have gone: Portable air filtration has been shown to reduce airborne particulate matter in homes, but direct evidence that it lowers household lead dust and children's blood lead is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* child under seven years of age with BLL \>5 µg/dL,
* child must reside in housing built before 1978, and
* child must sleep at home during participation in the two month-long study.

Exclusion Criteria:

* anything in child's health history that could affect the study results, or
* any circumstance that could interfere with guardian's/parent's ability to consent and/or participate in the study.

Where it's running

  • Michigan State University
    East Lansing, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Research on health impacts from World Trade Center dust exposure

    This study looks at how exposure to dust from the World Trade Center affects the health of local residents, cleanup workers, and first responders after 9/11.

    Recruiting NYU Langone Health · New York, New York · NCT00404898

  • Registry for patients with rare diseases

    This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.

    Recruiting Sanford Health · Sioux Falls, South Dakota · NCT01793168

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.